Stock comparison

AMGNvsREGN

Amgen IncvsRegeneron Pharmaceuticals Inc. Real data pulled from the alphactor.ai fundamentals pipeline — valuation, balance-sheet health, momentum, and analyst sentiment side by side.

AMGN

Amgen Inc

$348.62

+6.70%

Biotechnology$188.8BNASDAQ

REGN

Regeneron Pharmaceuticals Inc

$766.02

+3.34%

Biotechnology$79.2BNASDAQ

60-day price, rebased to 100

AMGN +1.97% · REGN +1.98%

Round-by-round

AMGN 3·REGN 2· 1tie

EdgeREGN

Valuation upside

-41.60% vs -22.60% to DCF fair value

EdgeREGN

Balance-sheet strength

Altman Z 1.78 vs 7.40

EdgeAMGN

Fundamental quality

Piotroski 8.00 vs 5.00 (of 9)

EdgeAMGN

Growth + margins

Rule-of-40 32.00 vs 27.20

Tie

60-day momentum

+1.97% vs +1.98% price return

EdgeAMGN

Market-cap liquidity

$188.8B vs $79.2B

Verdict

Across6categories,AMGNtakes the edge with3wins to2 (and 1 tie). Neither score is a buy signal on its own: run the full backtest and credibility tests on alphactor.ai before putting money on it.

Backtest a strategy onAMGNorREGN

Point-in-time backtests, 8-layer credibility pipeline, conviction scoring — free to start.